美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

iShares Health Innovation Active ETF

33.32

0.0000

成交量：11

成交額：368.57

市值：1,332.60萬

市盈率：- -

高：33.32

開：33.32

低：33.32

收：33.32

52周最高：34.86

52周最低：25.79

股本：40.00萬

流通股本：40.00萬

量比：0.22

換手率：0.00%

股息：0.08

股息率：0.24%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

丹納赫（DHR）旗下兩子公司聯合推出Cas9 mRNA解決方案賦能基因編輯研發加速落地

吉利德科學擴大六項免許可費自願授權協議，力推每年一次HIV預防藥Lenacapavir

上海萊士(002252.SZ)：「SR604注射液」進入Ⅲ期臨床試驗

上海萊士：SR604注射液進入Ⅲ期臨床試驗

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BMED"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.315,"timestamp":1789565996832,"preClose":33.315,"halted":0,"volume":11,"delay":0,"changeRate":0,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"09-16 09:46:37 EDT","open":33.315,"high":33.315,"low":33.315,"amount":368.57183,"amplitude":0,"askPrice":33.69,"askSize":1000,"bidPrice":33.61,"bidSize":1000,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":33.315,"sharesOutstanding":360000,"nav":33.210436,"aum":13284174.4,"dividendRate":0.002392,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.23,"preClose":33.315,"latestTime":"16:10 EDT","volume":6,"amount":199.89,"timestamp":1789503006991,"change":-0.085,"changeRate":-0.002551,"amplitude":0},"volumeRatio":0.215025,"impliedVol":0.0634,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.215025,"shares":400000,"dividePrice":0.0797,"high":33.315,"amplitude":0,"preClose":33.315,"low":33.315,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":33.315,"eps":0,"divideRate":0.002392,"volume":11,"delay":0,"ttmEps":0,"open":33.315,"prevYearClose":30.32,"prevWeekClose":32.965,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":33.0422,"twentyDayClose":32.666,"sixtyDayClose":28.5621},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667985488","title":"丹納赫（DHR）旗下兩子公司聯合推出Cas9 mRNA解決方案 賦能基因編輯研發加速落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2667985488","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667985488?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:57","pubTimestamp":1789563457,"startTime":"0","endTime":"0","summary":"金吾财讯 | 丹纳赫 旗下两家子公司——集成DNA技术公司与Aldevron宣布推出联合研发的科研级S.p. Cas9 mRNA解决方案，涵盖野生型及SpyFi高保真两种形式，旨在加速CRISPR基因编辑项目从早期研究向符合CGMP标准的临床开发转型。该联合方案结合了IDT在CRISPR基因工程与设计方面的专业知识，以及Aldevron在mRNA领域的规模化生产能力。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306117","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1366333091.USD","LU1923622614.USD","BK4534","LU0708995401.HKD","XT","LU0114720955.EUR","SYNB","TARK","CRSP","IE000M9KFDE8.USD","LU0432979614.USD","LU0689472784.USD","SG9999001176.USD","LU0390134368.USD","LU2106854487.HKD","BMED","BK4585","IE00BQXX3F31.USD","LU0289739343.SGD","LU1551013342.USD","SG9999004303.SGD","LU1267930730.SGD","WDNA","LU0289961442.SGD","LU1974910355.USD","IDNA","GNOM","LU2063271972.USD","DHR","FMED","LU2355687059.USD","DTEC","ARKG","NBDS","KOMP","LU0528227936.USD","FWD","LU2125910336.SGD","LU1804176565.USD","LU1551013425.SGD","LU1791710582.SGD","SGXZ57979304.SGD","LU0820561818.USD","LU2211814178.USD","LU0943347566.SGD","LU0289960550.SGD","HELX","LU0882574055.USD","IE00BQXX3C00.GBP","IE0004445239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164691459","title":"吉利德科學擴大六項免許可費自願授權協議，力推每年一次HIV預防藥Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=1164691459","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164691459?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:31","pubTimestamp":1789561872,"startTime":"0","endTime":"0","summary":"吉利德科学宣布，扩大其六项免许可费的自愿授权协议，覆盖其每年仅需注射一次的HIV预防药物Lenacapavir。此举旨在拓宽药物可及性，助力全球抗击艾滋病疫情。通过这一系列协议，吉利德希望加快该长效预防方案在中低收入国家的推广，以应对持续存在的公共卫生挑战。该举措不仅彰显了公司在全球健康公平方面的承诺，也为实现2030年终结艾滋病流行的目标注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","IBB","SG9999015952.SGD","LU1023059063.AUD","IE00B7SZLL34.SGD","LU0122379950.USD","LU1934455277.USD","LU2087621335.USD","BK4583","LU1037948541.HKD","LU0861579265.USD","LU0058720904.USD","LU0882574055.USD","IE00BKVL7J92.USD","SG9999015978.USD","IE00BSNM7G36.USD","LU1066051498.USD","LU1571399168.USD","TBXU","TMED","LU2089984988.USD","SG9999015986.USD","LU1430594728.SGD","LU1674673428.USD","GILD","BK4585","LU1585245621.USD","LU0965509101.SGD","LU0965509283.SGD","IE0002270589.USD","LU2468319806.SGD","LU0320765992.SGD","LU1066053197.SGD","LU2324357040.USD","LU0234570918.USD","LU1061106388.HKD","IE00B19Z3581.USD","LU0965508806.USD","LU0859254822.USD","LU0965509010.AUD","BK4139","LU0289739699.SGD","LU2357627491.SGD","LU1037948897.HKD","BK4566","BMED","BK4588","BK4532","IE00BZ1G4Q59.USD","IBBQ","BK4578","BK4568","LU0114720955.EUR","LU1778281490.HKD","MEDI","IE00B19Z3B42.SGD","BK4550","LU0889565916.HKD","BBH","LU1057294990.SGD","LU1934455863.HKD","LU1934455194.USD","LU2112291526.USD","BIB","LU0109394709.USD","LU1674673691.USD","LU0823416689.USD","LU1839511570.USD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988673","title":"上海萊士(002252.SZ)：「SR604注射液」進入Ⅲ期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988673","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988673?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 19:56","pubTimestamp":1789559791,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海莱士 发布公告，公司在研产品“SR604注射液”于近日在国家药品监督管理局药物临床试验登记与信息公示平台公示了“血友病A/B患者出血发作的预防治疗”Ⅲ期临床试验登记信息，试验名称：评价SR604注射液在有或无抑制物的血友病A/B患者中预防治疗的有效性和安全性的单臂、多中心Ⅲ期临床试验试验目的：评价SR604注射液在有或无抑制物的血友病A/B患者中预防治疗的有效性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PSYK","IBBQ","BK0028","IBBJ","BK0196","BK0188","MDTX","BK0239","BK0046","002252","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667498863","title":"上海萊士：SR604注射液進入Ⅲ期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2667498863","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667498863?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 19:51","pubTimestamp":1789559491,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","IBBQ","PSYK","MDTX","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BMED\",params:#limit:6,delay:false,,,undefined,":[]}}